BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dwyer BJ, Macmillan MT, Brennan PN, Forbes SJ. Cell therapy for advanced liver diseases: Repair or rebuild. J Hepatol 2021;74:185-99. [PMID: 32976865 DOI: 10.1016/j.jhep.2020.09.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Xue C, Gu X, Li L. Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinoma. Cancer Cell Int 2021;21:471. [PMID: 34488768 DOI: 10.1186/s12935-021-02183-5] [Reference Citation Analysis]
2 Ezhilarasan D. Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis. J Cell Physiol 2021. [PMID: 34514599 DOI: 10.1002/jcp.30582] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zhang K, Sun H, Cao H, Jia Y, Shu X, Cao H, Zhang Y, Yang X. The impact of recipient age on the effects of umbilical cord mesenchymal stem cells on HBV-related acute-on-chronic liver failure and liver cirrhosis. Stem Cell Res Ther 2021;12:466. [PMID: 34416908 DOI: 10.1186/s13287-021-02544-x] [Reference Citation Analysis]
4 Liu WM, Zhou X, Chen CY, Lv DD, Huang WJ, Peng Y, Wu HP, Chen Y, Tang D, Guo LN, Wang XL, Zhang HD, Liu XH, Yang LQ, Yu WF, Yan HX. Establishment of Functional Liver Spheroids From Human Hepatocyte-Derived Liver Progenitor-Like Cells for Cell Therapy. Front Bioeng Biotechnol 2021;9:738081. [PMID: 34858956 DOI: 10.3389/fbioe.2021.738081] [Reference Citation Analysis]
5 Zhu CH, Zhang DH, Zhu CW, Xu J, Guo CL, Wu XG, Cao QL, Di GH. Adult stem cell transplantation combined with conventional therapy for the treatment of end-stage liver disease: a systematic review and meta-analysis. Stem Cell Res Ther 2021;12:558. [PMID: 34717737 DOI: 10.1186/s13287-021-02625-x] [Reference Citation Analysis]
6 Li Y, Lu L, Cai X. Liver Regeneration and Cell Transplantation for End-Stage Liver Disease. Biomolecules 2021;11:1907. [PMID: 34944550 DOI: 10.3390/biom11121907] [Reference Citation Analysis]
7 Giancotti A, D'ambrosio V, Corno S, Pajno C, Carpino G, Amato G, Vena F, Mondo A, Spiniello L, Monti M, Muzii L, Bosco D, Gaudio E, Alvaro D, Cardinale V. Current protocols and clinical efficacy of human fetal liver cell therapy in patients with liver disease: A literature review. Cytotherapy 2022. [DOI: 10.1016/j.jcyt.2021.10.012] [Reference Citation Analysis]
8 Brennan PN, MacMillan M, Manship T, Moroni F, Glover A, Graham C, Semple S, Morris DM, Fraser AR, Pass C, McGowan NWA, Turner ML, Lachlan N, Dillon JF, Campbell JDM, Fallowfield JA, Forbes SJ. Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH). BMJ Open 2021;11:e053190. [PMID: 34750149 DOI: 10.1136/bmjopen-2021-053190] [Reference Citation Analysis]
9 Ma C, Zhang L, He T, Cao H, Ren X, Ma C, Yang J, Huang R, Pan G. Single cell Raman spectroscopy to identify different stages of proliferating human hepatocytes for cell therapy. Stem Cell Res Ther 2021;12:555. [PMID: 34717753 DOI: 10.1186/s13287-021-02619-9] [Reference Citation Analysis]
10 Ding Y, Li Y, Sun Z, Han X, Chen Y, Ge Y, Mao Z, Wang W. Cell-derived extracellular vesicles and membranes for tissue repair. J Nanobiotechnology 2021;19:368. [PMID: 34789267 DOI: 10.1186/s12951-021-01113-x] [Reference Citation Analysis]
11 Huang Y, Huang Z, Tang Z, Chen Y, Huang M, Liu H, Huang W, Ye Q, Jia B. Research Progress, Challenges, and Breakthroughs of Organoids as Disease Models. Front Cell Dev Biol 2021;9:740574. [PMID: 34869324 DOI: 10.3389/fcell.2021.740574] [Reference Citation Analysis]